Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes

PLoS One. 2010 Apr 21;5(4):e10249. doi: 10.1371/journal.pone.0010249.

Abstract

Background: The HLA-B*35-Px allele has been associated with rapid disease progression in HIV-1 infection, in contrast to the HLA-B*35-Py allele.

Methodology/principal findings: Immune responses to two HLA-B*35 restricted HIV-1 specific CTL epitopes and their variants were followed longitudinally during early HIV-1 infection in 16 HLA-B*35+ individuals. Subjects expressing HLA-B*35-Px alleles showed no difference in response to the consensus epitopes compared to individuals with HLA-B*35-Py alleles. Surprisingly, all the HLA-B*35-Px+ individuals responded to epitope-variants even in the absence of a consensus response. Sequencing of the viral population revealed no evidence of variant virus in any of the individuals.

Conclusions/significance: This demonstrates a novel phenomenon that distinguishes individuals with the HLA-B*35-Px rapid progressing allele and those with the HLA-B*35-Py slower progressing allele.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • CD4 Lymphocyte Count
  • CD8-Positive T-Lymphocytes / immunology*
  • Disease Progression
  • Epitopes, T-Lymphocyte / genetics
  • Epitopes, T-Lymphocyte / immunology*
  • Genetic Variation
  • HIV Infections / blood
  • HIV Infections / diagnosis
  • HIV Infections / immunology
  • HIV-1 / immunology*
  • HLA-B35 Antigen / genetics*
  • Humans
  • Longitudinal Studies
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocytes, Cytotoxic / immunology*
  • Viral Load

Substances

  • Epitopes, T-Lymphocyte
  • HLA-B35 Antigen